Graftys Renews Long-term Agreement with Arthrex

Graftys announced the renewal of its multi-year supply agreement with Arthrex for advanced synthetic bone graft materials.

Aurelien Valet, Graftys’ Chief Executive Officer, said, “We are proud that Arthrex has renewed its trust in Graftys through this long-term agreement which will provide multiple new business opportunities using...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us